Skip to main content Skip to search Skip to main navigation

Deviations Happen because People Make Mistakes...

8 min. reading time | by Thomas Peither
Published in LOGFILE 6/2023

In this feature we take look at the ‘black sheep’ of pharmaceutical production. As cute and charming as they may be in the animal world, in the world of GMP they can be rather disturbing.

They are the sand in the gears of smooth manufacturing that need to be identified, documented and investigated.

The trick here is not just to identify a single outlier, a black sheep, but also to recognise the grey animals that do not stand out at first glance.


What is a deviation? And what distinguishes it from a change?

Seemingly simple questions, but not so easy to answer at first glance. This is because there is no clear, generally applicable definition for the term ‘deviation’ in the various US and EU regulations.

To add to the confusion, different terms are often used: deviation, quality deviation, GMP deviation, product defect, OOS, discrepancy, atypical situation, non-conformity. Although these terms all suggest similar things, they are used to describe for very different events.

To avoid ambiguity and possible misunderstandings, each company must define what it means by a deviation. Generally speaking, a deviation is always unintentional, i.e. unplanned and retrospectively.

In contrast, a change is a planned and intentional modification, such as the addition or replacement of regulations, specifications, equipment, methods or processes. A change is therefore always prospective. It has a long-term or even permanent character.

In order to structure the internal handling of deviations, an overview of frequently used definitions of deviations is helpful. If these are as comprehensive as possible, relevant data from different areas can be collected together and evaluated comparatively.


Where do deviations occur?

Deviations can occur in the area of production and packaging, for example in connection with

  • manufacturing instructions,
  • process parameters or specifications,
  • test specifications for in-process controls or
  • in-process specifications.

Process abnormalities or unexpected machine stops during production or packaging cannot be excluded.

Deviations can also occur during quality control, for example if test specifications are deviated from or if OOS, OOT or OOE results occur. And, of course, we are also aware of any deviations relating to machines, systems, equipment, rooms or media. Machines brak down from time to time and systems fail from time to time. Temperature, humidity, particle counts, pressure differences or calibration results may be outside the limits. Calibration or maintenance intervals are sometimes not adhered to, or there are deviations in microbiological monitoring, to name but a few.

Processes can also be prone to error, for example if SOPs are not followed exactly. Even warehouses are not immune to irregularities. Keywords: pest control or temperature fluctuations.



What types of deviations are there?

Basically, a distinction can be made between batch-specific and non-batch-specific deviations. The above mentioned events, which can occur during the manufacturing process, usually directly affect batches and may have an impact on product quality. This means: the safety, quality, identity, purity or content of the product is affected.

However, even in the case of non-batch-specific deviations, for example in the context of environmental monitoring in cleanroom Grade C, the possible influence on individual batches must always be assessed as part of the investigation.


A translated and shortened excerpt from episode 30 of the German webcast GMP & TEA ‘Deviations happen because people make mistakes...


Do you need more information about handling deviations?

In the GMP Compliance Adviser, you will learn, among other things, what is behind a deviation that should not actually exist, the planned deviation, what the regulatory requirements are for handling deviations, how deviations are handled in a GMP-compliant manner, and what all it all has to do with the qualified person.


Do you have any questions or suggestions? Please contact us at: redaktion@gmp-verlag.de

Thomas Peither
Thomas Peither

You may also be interested in the following articles:

News: EMA

EMA Clarifies Batch Numbering for Parallel-Traded Medicines

EMA updated its GMP/GDP Q&A collection by revising the answer to Question 4 concerning Chapter 5 of the EU GMP Guide. It explains which batch numbers should appear on the packaging of parallel-traded medicines.

Read more
Question of the Week | GMP-Verlag

Why is it Important to use Consistent Microbiological Air Monitoring Methods in Pharmaceutical Cleanrooms?

Here's the answer:
Read more
Cleaning Validation: When PDE Reports and the Worst-Case Selection do not Align

Cleaning Validation: When PDE Reports and the Worst-Case Selection do not Align

Robust PDE reports form the basis of risk-based cleaning validation. This article highlights common deficiencies identified during GMP inspections and explains how they can be avoided.

Read more
News: Europe

EDQM: New Working Party on 3D-printed Medicinal Products

The European Pharmacopoeia Commission (EPC) approved the creation of a working party on 3D-printed medicinal products. Its aim is to support the development of appropriate quality standards in the European Pharmacopoeia (Ph. Eur.).
Read more
EMA: 14 New Nitrosamines for Appendix 1

EMA: 14 New Nitrosamines for Appendix 1

Appendix 1 of EMA’s Questions and Answers on nitrosamine impurities has been updated. This appendix contains acceptable intakes (AIs) established for N-nitrosamines.
Read more
WHO: Draft Revision of its Guidelines on Quality Risk Management

WHO: Draft Revision of its Guidelines on Quality Risk Management

WHO published a revised draft of its “WHO guidelines on quality risk management”. Working document QAS/26.994 is open for public comment until 15 November 2026.
Read more
Previous
Next

Related Products

Skip product gallery
GMP Compliance Adviser | Named User Licence | 12M

GMP Compliance Adviser | Named User Licence | 12M

With an named user licence, one user can access the knowledge portal; with a corporate licence, any number of users can access it.Approx. 5,000 pages of practical GMP knowledge with illustrations and forms: Practical guidance for rapid implementation in the workplaceDetailed descriptions of GMP-compliant systemsInternational laws and guidelines Always up-to-date thanks to regular updates Download Advantages and Prices60+ Sample Documents In addition, the GMP Compliance Adviser contains more than 60 sample documents (MS Office) and practical examples that you can use.Sample SOPsSample FormsSample ReportsSample DocumentationChecklistsProcess Diagrams (Flowcharts)Practical Examples of QRM Application (e.g., Risk Analyses)Sample Documents for Qualification and ValidationCase StudiesWritten by more than 80 authors with hands-on experience directly linked to the industryA team of over 80 experts interpret regulatory requirements and describe how they are implemented in practice.The authors are experienced in the pharmaceutical industry, consulting, and government agencies.

delivery immediately after receipt of payment
€1,368.00 net excl. VAT
GMP:KnowHow Pharma Logistics (GDP) | Named User Licence | 12M

GMP:KnowHow Pharma Logistics (GDP) | Named User Licence | 12M

Your knowledge portal for GDP-compliant pharmaceutical logistics.  It is important that you as a logistics service provider, but also as a client in the pharmaceutical industry, comply with regulatory requirements. The GMP:KnowHow knowledge portal guides you through the complex regulatory landscape of the pharmaceutical and logistical supply chain! The knowledge portal gives you an easy-to-understand overview of all the important topics. Interactive graphics help you navigate all areas covered by the EU GDP Guidelines (2013/C 343/01). You also have the relevant passages of the regulations directly at hand for each topic. This allows you to compare the requirements directly and saves valuable research time.One thing is certain: the knowledge portal answers your questions about the supply chain of medicinal products, active pharmaceutical ingredients and medical devices. You don't have to be an expert. Yet.You will find answers to your questions in the GMP:KnowHow Pharma Logistics (GDP). Where does GDP begin, where does GMP end? What does GDP-compliant mean? When do I also have to take GMP requirements into account? What permits do I need for certain activities? What requirements do I have to fulfil? What is the current legal basis? How am I covered? What authorizations do I have for my work, e.g. from my employer? Who is responsible — the client or the contractor? And many more What is the difference to the GMP Compliance Adviser? GMP:KnowHow Pharma Logistics (GDP) is a practical knowledge portal dedicated to Good Distribution Practice (GDP). It is a product that is independent of the GMP Compliance Adviser and concentrates on content that is essential for carriers of medicinal products, active pharmaceutical ingredients and medical devices as well as for logistics clients. The focus is on practical knowledge and how to apply it in your daily business. If necessary, the relevant regulations can be called up immediately alongside the practical knowledge, and you can see the relevant paragraphs at a glance. In addition, sample documents are available to help you make immediate progress. AuthorSimone Ferrante, currently Director Quality at Fisher Clinical Services, previously served as Head of Quality Control and Responsible Person (GDP) for the Grieshaber Group. She is also a long-standing author and GDP expert at GMP-Verlag.

delivery immediately after receipt of payment
€610.00 net excl. VAT
E-Learning GMP:READY | Specialist Knowledge GMP for Engineers

E-Learning GMP:READY | Specialist Knowledge GMP for Engineers

Why are GMP rules important for technicians and engineers? Technicians and engineers play a key role in ensuring compliance with Good Manufacturing Practice (GMP) standards. They are involved in critical activities such as: planning and construction of ventilation systems, maintenance of water treatment plants, calibration of measuring sensors. Therefore, they are jointly responsible for the quality of medicines and must ensure that their work complies with GMP standards.Your advantages: Fast familiarization with GMP topics in approx. 2 hours, time- and location-independent online training, printable personal certificate, 12-month access for initial and follow-up training, automatic updates in case of legal changes,content compliant with Article 7(4) of Directive 2003/94/EC.The Author This e-learning course was developed with the collaboration of Dipl.-Ing. Andreas Nuhn (D & B Pharmadesign GmbH).

delivery time appr. 2-5 workdays after receipt of payment
€245.00 net excl. VAT
GMP Fundamentals | A Step-by-Step Guide

GMP Fundamentals | A Step-by-Step Guide

This handbook is a practical and easy to read guideline, giving you a quick and comprehensive overview of the complex world of Good Manufacturing Practice (GMP) without the need of previously acquired knowledge. Some topics are: GMP: Purpose and basic pharmaceutical terms Laws, licenses and inspections Personnel: Responsibility and hygiene Standard Operating Procedures (SOP) and documentation Design of rooms and facilities Processing and packaging Quality control and market release Suppliers, storage and logistics (Good Distribution Practice = GDP) Alphabetical index and abbreviations Using practical examples and comparisons to every-day life will help to easy understand GMP regulations.GMP Fundamentals is a helpful guide which facilitates the entry into the GMP world and teaches the necessary basics.

delivery immediately after receipt of payment
€44.90 net excl. VAT